Daily Stock Analysis, GNMK, GenMark Diagnostics Inc, priceseries

GenMark Diagnostics Inc. Daily Stock Analysis
Stock Information
Open
5.52
Close
5.55
High
5.60
Low
5.45
Previous Close
5.52
Daily Price Gain
0.03
YTD High
8.37
YTD High Date
Feb 22, 2019
YTD Low
4.62
YTD Low Date
Jan 2, 2019
YTD Price Change
0.73
YTD Gain
15.15%
52 Week High
8.37
52 Week High Date
Feb 22, 2019
52 Week Low
3.58
52 Week Low Date
Dec 21, 2018
52 Week Price Change
0.39
52 Week Gain
7.56%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 24. 2017
11.25
Mar 28. 2017
12.67
22 Trading Days
12.65%
Link
LONG
Jan 8. 2018
5.16
Jan 9. 2018
5.49
1 Trading Days
6.44%
Link
LONG
Jan 19. 2018
4.83
Jan 30. 2018
5.38
7 Trading Days
11.46%
Link
LONG
Apr 13. 2018
5.45
Apr 30. 2018
6.26
11 Trading Days
14.91%
Link
LONG
Jul 31. 2018
6.68
Aug 23. 2018
7.15
17 Trading Days
7.03%
Link
LONG
Dec 26. 2018
4.39
Jan 23. 2019
5.74
18 Trading Days
30.76%
Link
LONG
Feb 20. 2019
6.73
Mar 5. 2019
7.41
9 Trading Days
10.10%
Link
Company Information
Stock Symbol
GNMK
Exchange
NasdaqGM
Company URL
http://www.genmarkdx.com
Company Phone
(760) 448-4300
CEO
Hany Massarany
Headquarters
California
Business Address
5964 LA PLACE COURT, CARLSBAD, CA 92008
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001487371
About

GenMark Diagnostics, Inc. is a molecular diagnostics company. The firm focuses on the development and commercializing of its its proprietary eSensor detection technology. It also manufactures, sells, and supports instruments and molecular tests. The company was founded by Jon Faiz Kayyem on February 12, 2010 and is headquartered in Carlsbad, CA.

Description

GenMark Diagnostics, Inc., a molecular diagnostics company, develops and commercializes molecular tests based on its proprietary eSensor electrochemical detection technology. The company provides XT-8 instrument, and related diagnostic and research tests, as well as certain custom manufactured reagents that enable reference laboratories and hospitals to support a range of molecular tests with a workstation and disposable test cartridges. It offers diagnostic tests for use with its XT-8 system that includes respiratory viral panel, cystic fibrosis genotyping test, warfarin sensitivity test, and thrombophilia risk test, as well as HCV genotyping test and associated custom manufactured reagents, and 2C19 genotyping test. The company also provides ePlex instrument and RP panel, which integrates automated nucleic acid extraction and amplification with its eSensor detection technology to enable operators using ePlex system to place patient sample directly into its test cartridge and obtain results without any additional steps. The company sells its products through direct sales and technically specialized service organization in the United States and Europe. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.